About Atheric Pharmaceutical

About company

Atheric™ Pharmaceutical LLC is a biopharmaceutical company focused on the rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus disease. Atheric's lead drug products are reformulated broad spectrum antiviral drugs that inhibit autophagy-dependent viral replication as well as other anti-viral pathways. Atheric is committed to providing broad-spectrum medical countermeasures for Zika and other neglected tropical diseases.